BETHESDA, Md., Sept. 8, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that Israeli patients with a medical cannabis license will now have access to Cannabics Pharmaceutical's cannabis oil Capsules.

Cannabics Pharmaceuticals executed an IP Licensing and Collaboration Agreement in Israel with Bazelet Pharma for the distribution of the Company's medical cannabis capsules in Israel through approved medical cannabis growers and in strict compliance with all laws and regulations in Israel.

From October 1, 2015, patients in Israel with a medical cannabis license shall be entitled to receive Cannabics oil capsules. These capsules are offered in two dosages: 1. Hermon-SR 10mg THC   2. Gilboa-SR 9.5mg THC, 0.5mg CBD.

"In recent years, Israel has become a superpower in the field of medical cannabis and we are excited about the opportunity to collaborate with the finest cannabis growers in Israel," said Dr. Eyal Ballan, Chief Scientist of Cannabics.

Last month Cannabics Pharmaceuticals announced that WanaCapsXR  capsules are sold in every region of Colorado. WanaCaps XR is the result...